Medical Hypotheses
Volume 52, Issue 6 , Pages 525-527, June 1999

Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease

  • A. McShea

      Affiliations

    • Bristol-Myers Squibb, Pharmaceutical Research Institute, Seattle, Washington, DC, U.S.A.
    • ,
  • A.F. Wahl

      Affiliations

    • Bristol-Myers Squibb, Pharmaceutical Research Institute, Seattle, Washington, DC, U.S.A.
    • ,
  • M.A. Smith

      Affiliations

    • Institute of Pathology, Case Western Reserve University, Cleveland, OH, U.S.A.

Received 24 July 1997; accepted 15 October 1997.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0306-9877(97)90680-0

doi:10.1054/mehy.1997.0680

Medical Hypotheses
Volume 52, Issue 6 , Pages 525-527, June 1999

Article Tools